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Treatment of denture-related stomatitis improves 
endothelial function assessed by flow-mediated 
vascular dilation
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A b s t r a c t
Introduction: The presence of oral inflammation has recently been linked 
with the pathogenesis of cardiovascular diseases. While numerous studies 
have described links between periodontitis and endothelial dysfunction, lit-
tle is known about the influence of denture-related stomatitis (DRS) on car-
diovascular risk. Therefore, the aim of this study was to determine whether 
the treatment of DRS can lead to improvement of the clinical measures of 
vascular dysfunction.
Material and methods: The DRS patients were treated with a local oral an-
tifungal agent for 3 weeks. Blood pressure, flow-mediated dilatation (FMD) 
and nitroglycerine-mediated vascular dilatation (NMD) were measured 
during three study visits: before treatment, one day and two months after 
conclusion of antifungal therapy.
Results: Flow-mediated dilatation measurements showed significant im-
provement of endothelial function 2 months after treatment (FMD median 
5%, 95 CI: 3–8.3 vs. 11%, 95% CI: 8.8–14.4; p < 0.01), while there was no 
difference in control, endothelium-independent vasorelaxations (NMD; me-
dian = 15.3%, 95% CI: 10.8–19.3 vs. 12.7%, 95% CI: 10.6–15; p = 0.3). Other 
cardiovascular parameters such as systolic (median =  125 mm Hg; 95% CI: 
116–129 vs. 120 mm Hg, 95% CI: 116–126; p = 0.1) as well as diastolic blood 
pressure and heart rate (median = 65.5 bpm, 95% CI: 56.7–77.7 vs. 71 bpm, 
95% CI: 66.7–75; p = 0.5) did not change during or after the treatment.
Conclusions: Treatment of DRS is associated with improvement of endo-
thelial function. Since endothelial dysfunction is known to precede the de-
velopment of severe cardiovascular disorders such as atherosclerosis and 
hypertension, patients should be more carefully screened for DRS in general 
dental practice, and immediate DRS treatment should be advised.
Key words: denture, Candida albicans, nystatin, blood pressure, endothelial 
dysfunction.
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Introduction
Inflammatory processes in the oral cavity have 
recently been linked to the pathogenesis of sys-
temic diseases, such as cardiovascular diseases 
[1–5] or rheumatoid arthritis [6]. Most studies 
have focused on the links between periodontitis 
and vascular disease including atherosclerosis 
[1–5]. Periodontal disease is an important risk 
factor for these disorders, and it has been shown 
that intensive hygiene phase therapy alleviates 
endothelial dysfunction in a long-term follow up, 
with clinical benefit lasting up to 6 months after 
treatment [7]. Mechanisms which link oral inflam-
mation and cardiovascular effects are not yet fully 
described, but one of the most important hypoth-
eses is the preactivation of the immune system. 
Local inflammation in the oral cavity may trigger 
systemic inflammation, with the production of in-
terleukin (IL)-6, C-reactive protein (CRP), tumour 
necrosis factor (TNF)-α and other proinflammato-
ry cytokines [7, 8], as well as activation of a cellu-
lar immune response [9]. 
Similarly to periodontitis, denture-related sto-
matitis (DRS) is an inflammatory process localized 
in the oral cavity. Denture-related stomatitis is an 
important clinical issue in elderly patients, making 
it particularly relevant in the light of the ageing 
of western societies. Denture-related stomatitis 
affects up to 70% of patients during the course of 
life [10, 11], with erythema and swelling of pala-
tal mucosa being the main clinical symptoms. Be-
cause of the non-specificity of these symptoms, 
this disease often remains undiagnosed and un-
treated for long periods of time. The etiology of 
DRS is multifactorial [10] but is associated with 
long-term and continuous use of dentures and 
poor denture and oral hygiene habits which pro-
mote disease development [10, 12]. The pres-
ence of denture, together with other favourable 
conditions, such as low salivary pH, regular sugar 
consumption [13] and local immune surveillance 
changes [14], promote excessive growth of Can-
dida albicans, which is a fungal component of the 
physiological microflora of the human oral cavity 
[15, 16]. Consequently, Candida infection develops 
and DRS occurs.
While numerous studies have focused on the 
links between periodontitis and endothelial dys-
function, little is known about the links between 
other forms of oral infection and inflammation in 
the context of cardiovascular risk. Interestingly, in-
creased cardiovascular risk has been shown also 
for caries [17, 18], as well as endodontic infection 
[19–21]. These diseases are all caused by bacterial 
infections, while fungal oral cavity infections have 
not been studied in this context. We found only 
one study, by Buhlin et al. [2], describing a positive 
association between the use of dentures and the 
prevalence of cardiovascular diseases. However, 
the group defined as “denture users” was very 
heterogeneous, and it remains unclear how many 
denture users suffered from DRS, as the study 
was based on a patient questionnaire, making it 
difficult to draw firm conclusions. More recently 
we have described the presence of vascular en-
dothelial dysfunction in DRS patients, compared 
to the denture patients with healthy oral muco-
sa [22]. Since endothelial dysfunction is known 
to precede the development of hypertension and 
atherosclerosis [23] with its complications, such 
as heart attack and stroke, it is essential to clarify 
the influence of DRS on the endothelial function. 
As the prevalence of DRS in elderly denture us-
ers is high, this could make DRS a very significant 
novel cardiovascular risk factor. 
To study the cause and effect relationship be-
tween DRS and endothelial dysfunction, an inter-
ventional study is necessary. Therefore, the aim of 
this study was to determine whether the treatment 
of local inflammation associated with DRS influ-
enced the clinical measures of vascular dysfunc-
tion, such as endothelial function or blood pressure.
Material and methods
Patients and clinical evaluation
One hundred and twenty-eight patients us-
ing dental prostheses for at least 6 months were 
screened for clinical symptoms of oral mucosal 
inflammation such as erythema, swelling, discom-
fort and pain in the palatal area. In patients with 
teeth present clinical periodontal pocket depth 
was measured at six points around each tooth 
to exclude the presence of periodontitis. Patients 
with one or more periodontal pocket depth ≥ 4 mm 
were excluded from the studies. Exclusion criteria 
also included acute inflammatory disorders oth-
er than DRS, neoplastic disease or its relapses and 
chemotherapy courses less than 5 years before the 
enrolment, antibiotics regimen in the preceding 
4 weeks or anti-inflammatory drugs (steroids and 
non-steroidal, excluding aspirin in doses lower than 
80 mg) in the preceding 2 months before the enrol-
ment. Patients with a history of myocardial infarc-
tion, acute coronary incident or vascular inflamma-
tion in 5 weeks or less before the enrolment, chronic 
haematological disorders and immunodeficiency or 
major medication changes within 5 weeks before or 
during the study were also excluded. 
Swabs from the inflamed area were obtained 
from n = 20 subjects for the microbiological cul-
ture for the presence of Candida species to con-
firm the clinical diagnosis of DRS. Seventeen pa-
tients were recruited to the interventional study 
when clinical diagnosis was confirmed by the 
culture of Candida species from the palatal mu-
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cosa (Figure 1). Treatment of oral fungal infec-
tion included application of nystatin (100 000 IU/
ml) every 6 h for 2 weeks on the infected area 
of the mucous membrane of the palate. This 
was done by administrating 5 drops of nystatin 
suspension on the palatal side of the denture 
and placing it on the palatal mucosa. Patients’ 
dentures were evaluated by a  clinician, and if 
indicated, dentures were replaced for the new 
ones during nystatin treatment. Use of any oth-
er concomitant medications was monitored and 
remained unchanged throughout the study pe-
riod. Blood pressure, flow-mediated (FMD) and 
nitroglycerine-mediated (NMD) vascular dilata-
tion data were measured in all patients during 
three visits: the first data set was obtained be-
fore commencement of the treatment regimen 
(visit 1), the second immediately after conclu-
sion of treatment to assess the direct influence 
of therapy (visit 2), and the third 2 months af-
ter completion of treatment to assess long-
term effects of termination of infection (visit 3). 
At the same time, a swab from mucosal tissue was 
taken during visit 2 to confirm the effectiveness 
of the antimicrobial treatment and Candida spe-
cies eradication. While randomization to a place-
bo group would be valuable, it has been deemed 
unethical in patients clearly requiring treatment. 
The study was reviewed and approved by the 
local ethics committee of Jagiellonian University. 
Written informed consent was obtained from all 
patients, and the study was conducted in accor-
dance with the Declaration of Helsinki. This study 
has been registered in ClinicalTrials.gov (identifi-
cation no. NCT02166450). 
Microbiological investigations
Swabs were taken from the hard palate (be-
tween the second and third palatal fold). Sam-
ples were collected after an overnight fast and 
after at least 6 h of denture using, without its 
cleaning, use of adhesives or rinsing the mouth 
with disinfectants. The material was collected in 
accordance with the general principles of micro-
bial material collection. Candida identification 
was made according to the colour of the colony 
on CHROMagar Candida medium (Graso Biotech, 
Starogard Gdanski, Poland) after 36 to 48 h of in-
cubation at 36°C. 
Clinical data
Patients’ blood pressure (systolic, diastolic) was 
monitored for 24 h using an ambulatory blood 
pressure monitoring system (SpaceLabs90217, 
Ultralite). Systolic, diastolic and mean arterial 
pressures were recorded every 20 min for 24 h. 
Day and night averages were calculated. One pa-
tient did not agree to wear the ambulatory blood 
pressure monitoring system. Major risk factors 
for both atherosclerosis and DRS were recorded 
based on patient medical records and detailed 
patient medical history obtained during the inter-
view. Clinical risk factors were defined as follows: 
hyperlipidaemia (total plasma cholesterol level 
> 5 mmol/l and/or triglycerides level > 1.7 mmol/l); 
diabetes (fasting glucose level ≥ 7 mmol/l or gly-
cated haemoglobin (HbA1c) > 6.5% or current 
treatment with insulin or oral hypoglycaemic 
agents); hypertension (blood pressure ≥ 140/ 
90 mm Hg or current treatment with antihyperten-
sive agents), and smoking (current or within last 
6 months) [24]. Blood samples were obtained 
from the antecubital vein and lipoprotein profile 
was assessed by measurements of triglycerides, 
Figure 1. Study design for screening and recruit-
ment of the DRS patients
Complete and partial 
denture users (n = 128)
Negative Candida species 
culture
Exclusion criteria: 
Teeth with periodontal pocket 
depth ≥ 4 mm present
Exclusion criteria: 
•	Acute inflammatory disorders
•	Neoplastic disease or its 
relapses < 5 years before the 
enrolment
•	Chemotherapy < 5 years 
before the enrolment
•	Antibiotics regiment  
< 4 weeks before the 
enrolment
•	Anti-inflammatory drugs 
(steroids and non-steroidal) 
< 2 months before the 
enrolment 
•	History of myocardial 
infarction, acute coronary 
incident or vascular 
inflammation in ≤ 5 weeks 
before the enrolment
•	Chronic haematological 
disorders or 
immunodeficiency < 5 weeks 
before or during study
•	Major medication changes  
< 5 weeks before or during 
study
Complete and partial 
denture users (n = 96)
Complete and partial 
denture users (n = 20)
Complete and partial 
denture users;  
denture-related 
stomatitis patients  
(n = 17)
n = 32
n = 76
n = 3
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total cholesterol, and low- and high-density lipo-
protein cholesterol fractions. C-reactive protein 
concentration was also assessed. 
Subclinical atherosclerosis
To characterize subclinical atherosclerosis, as-
sessment of carotid artery intima-media thickness 
was performed. It was measured at 12 different 
points (2 cm below common carotid arteries bulbs, 
ca. every 1 cm, omitting visible coronary plaques), 
on right and left common carotid artery, measur-
ing the distance between the border between the 
artery lumen and carotid artery intima and second 
bright line-m (border between media and adventi-
tia) as described previously [25].
Endothelial function measurement
The FMD method was used to determine the 
vascular endothelial function and NMD for mea-
suring endothelial-independent vasodilatation. 
Measurements were conducted using the Toshiba 
Xario Diagnostic Ultrasound System after 1, 2 and 
4–5 min after manometer cuff deflation or sub-
lingual administration of nitroglycerine and pre-
sented as percentage of the diameter of the artery 
before intervention. Method validation in our lab-
oratory has been described before [25]. Observers 
were blinded regarding oral status of the patients.
Statistical analysis
Assessment of normality of distribution for all 
tested continuous variables was conducted by the 
Shapiro-Wilk test. Variables whose distributions 
were not consistent with normal distribution are 
presented as the median and 25th (Q1) and 75th 
(Q3) percentiles, and values for subsequent visits 
were compared by the Friedman test, with post-
hoc analysis in case of detecting significance. Vari-
ables with normal distribution are presented as 
mean ± standard deviation (SD). All variables with 
normal distributions described baseline group 
characteristics, and comparison between visits 
was not applicable. The method of presentation of 
results is given for each variable in the text. Val-
ues of p < 0.05 were considered statistically signif-
icant. All analyses were performed with StatSoft 
Statistica software (StatSoft, Inc., Tulsa, OK, USA).
Results
Study population characteristics
Clinical characteristics of studied patients are 
shown in Table I. Patients were mostly women 
(n = 14; 82.3%) with mean age 62.8 ±6.0 years and 
mean BMI 28.9 ±5.8 kg/m2. 35.3% of patients were 
current smokers and diabetics, which is of particu-
lar significance, as these features are key risk fac-
Table I. Clinical characteristics of studied groups
Parameter Result
Number of patients 17
Age [years] 62.8 (6.0)
Gender (M : F) 3 : 14
Maxillary dentures:
Partial 3 (18%)
Complete 14 (82%)
Mandibular dentures:
Partial 3 (18%)
Complete 14 (82%)
BMI: 28.9 (5.8)
Overweight 5 (29.4%)
Obesity 6 (35.3%)
Cigarette smoking:
Current smokers 6 (35.3%)
Past smokers 1 (5.9%)
Accompanying diseases:
Diabetes 6 (35.3%)
Coronary artery disease 7 (41.2%)
Hypertension: 15 (88.2%)
Controlled 7 (41.2%)
Untreated 8 (47.1%)
Hyperlipidaemia 12 (70.6%)
Medications:
ACE inhibitor 9 (52.9%)
Acetylsalicylic acid 8 (47.1%)
α-Blocker 1 (5.9%)
β-Blocker 8 (47.1%)
Calcium antagonist 6 (35.3%)
Diuretic 9 (52.9%)
Statin 11 (64.7%)
Insulin 1 (5.9%)
Oral antidiabetic agents 4 (23.5%)
Carotid artery intima media thickness 
[mm]
0.85 (0.22)
Atherosclerotic plaque presence 7 (41.2%)
Blood lipid characteristics:
Total cholesterol [mmol/l] 5.7 (1.3)
Triglycerides [mmol/l] 1.7 (0.7)
HDL cholesterol [mmol/l] 1.4 (0.4)
LDL cholesterol [mmol/l] 3.5 (1.1)
Blood CRP levels [mg/ml] 2.5 (3.4)
Data are presented as mean (SD) or n (%). ACE – angiotensin 
converting enzyme, BMI – body mass index, CRP – C-reactive 
protein, F – females, HDL – high-density lipoproteins, LDL – low-
density lipoproteins, M – males.
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tors for DRS. Eighty-eight percent of patients were 
hypertensive. Only 3 out of 17 patients did not use 
any medications, and the most commonly used 
were statins (65% of patients), followed by angio-
tensin-converting enzyme (ACE) inhibitors and di-
uretics (53% each) and β-blockers and acetylsali-
cylic acid (47%). Use of cardiovascular medications 
was monitored and remained unchanged through-
out the study. Despite the fact that almost half of 
the recruited patients (41%) presented with athero-
sclerotic lesions, mean carotid artery intima-media 
thickness did not exceed standard values.
Clinical effectiveness of treatment
Treatment was effective in all studied patients 
and improvement was seen in both the clini-
cal signs and negative oral Candida swabs. This 
improvement persisted during subsequent two-
month observation, with no recurrences of DRS 
(Table II). 
Vascular function assessment
Flow-mediated dilatation  measurements, which 
indicate endothelium-dependent vessel function 
and its ability to constrict and dilate depending 
on the physiological needs of the cardiovascular 
system, showed significant improvement in me-
dian percentage of arterial dilation in response 
to flow in the DRS patients between the visit be-
fore and 2 months after treatment (Figure 2 A). 
Furthermore, after completion of the treatment 
the endothelium-dependent vascular function 
continued to improve, showing that resolution 
of chronic inflammation in the oral cavity brings 
significant benefits for the endothelial physiology 
(Figure 2 A). At the same time, there was no differ-
ence in values of endothelium-independent vaso-
dilatation (NMD) (Figure 2 B).
Blood pressure analysis
Median systolic and diastolic blood pressure 
of DRS patients showed no significant changes 
throughout treatment (Figures 3 A, C). Similarly, no 
differences were observed in the median mean ar-
terial and pulse pressure (Figures 3 B, D). Treatment 
of DRS did not affect systolic and diastolic blood 
pressure values during either activity or rest peri-
ods (daytime/night-time blood pressure; Figure 3).
Table II. Effectiveness of DRS treatment
Variable Pre-treatment 
screening
One day after therapy 
completion
Two months after therapy 
completion
Redness of the mucosa 100% 0% 0%
Swelling of the mucosa 47% 6% 0%
Discomfort and pain 76% 18% 6%
Positive culture of Candida species 100% 0% N/A
Data are presented as % of total number of patients. N/A – not applicable, microbiological investigations was not performed.
Figure 2. Vascular dysfunction in DRS patients treated with nystatin. Vascular endothelium-dependent flow-me-
diated dilatation (A) and endothelium-independent nitroglycerine-mediated dilatation (B) parameters were as-
sessed by ultrasonography before starting nystatin therapy, immediately after finishing it and 2 months after 
therapy completion
Results presented as median (box: Q1–Q3; whisker: minimal and maximal measurements). #p < 0.05 for comparison of 2nd and 
3rd visit; ¶p < 0.05 for comparison of 1st and 3rd visit. 
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Discussion
The links between the general and oral health 
have become the object of keen interest among 
researchers and clinicians in recent years. The 
impact of oral conditions on various diseases, 
including rheumatoid arthritis [26], obesity [27], 
peptic ulcers [28], negative pregnancy outcomes 
[29], diabetes [30] and in epilepsy [31] has been 
investigated. However, most studies have focused 
predominantly on bacterial infections in the oral 
cavity such as periodontitis, caries or endodontic 
infections. At the same time, DRS, being inflam-
mation of oral mucosa related primarily to fungal 
infection, has not been widely studied in relation 
to vascular disease to date. 
In our study, we demonstrated for the first 
time that the benefits from successful treatment 
of DRS extend beyond the oral cavity and lead to 
an improvement in vascular dysfunction. Endo-
thelium-dependent, flow-induced brachial artery 
dilatation steadily improved during the treatment 
and reached statistical significance 2 months af-
ter finishing the therapy, showing a significant im-
provement in vascular function, while the control, 
nitroglycerine-induced endothelium-independent 
vasodilatation remained unchanged. This obser-
vation is therapeutically important and extends 
our recent report that vascular function is im-
paired in DRS [22]. While the previously described 
link could have been attributed to confounding 
factors, such as diabetes, the results presented in 
this paper show that endothelial function in DRS 
is directly related to oral infection and removal of 
this pathology results in significant improvement 
of vascular health. 
While it was not possible to study a  placebo 
group for ethical reasons, this effect is unlikely to 
 Systolic           Diastolic           Mean arterial           Pulse
Figure 3. Blood pressure characteristics in periods of rest and activity in DRS patients treated with nystatin. Com-
parison of systolic and diastolic blood pressure (A, C) and mean arterial and pulse pressure (B, D) in DRS patients be-
fore starting nystatin therapy, immediately after finishing it and 2 months after therapy completion during activity  
and rest periods of the day. 24-hour measurement of blood pressure was performed using an ambulatory blood 
pressure monitoring system
Results presented as median (box: Q1–Q3; whisker: minimal and maximal measurements).
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be related to the placebo effect or direct nystatin 
use, as the improvement of endothelial function 
was maintained for subsequent months after oral 
inflammation was removed.
While our study is the first to show the effects 
of DRS therapy on endothelial function, previous 
studies have shown similar improvements in rela-
tion to other oral diseases, particularly periodon-
titis. Two research groups have presented results 
showing that subjects with advanced periodontal 
disease exhibit worse endothelial function when 
compared to the healthy controls [32]. Moreover, 
periodontal treatment leads to the improvement 
of endothelial function as a long-term outcome [7, 
33]. One of these studies was a randomized con-
trolled trial which showed that such improvement 
provides clinical benefit for up to 6 months after 
intensive treatment of chronic periodontitis [7].
The importance of our observation is particu-
larly significant because it its known that sever-
ity of endothelial dysfunction not only correlates 
with the development of coronary artery disease, 
but may also predict future cardiovascular events. 
This is also of great importance given that DRS is 
one of the most common oral disorders, affecting 
40–70% of elderly denture wearers [10, 11], and 
its frequency might possibly increase because 
of ageing of the world population. In the light of 
these facts, the results of our study have clinical-
ly important implications for the management of 
patients with DRS. Patients with DRS should be 
identified early through screening during patients’ 
visits to their dentist and where diagnosed should 
be treated timely and thoroughly in order to elim-
inate this as a source of systemic inflammation.
In our study, we did not observe a significant 
influence of DRS treatment on blood pressure 
values. Since endothelial dysfunction is known 
to precede the development of hypertension and 
atherosclerosis [23], it is possible that the obser-
vation period was too short for such effects to be-
come detectable. On the other hand, it is in line 
with our previous study, where we also did not ob-
serve an association between DRS presence and 
blood pressure values. This aspect was also stud-
ied by Buhlin et al. [2], who reported a  positive 
association between using dentures and all car-
diovascular diseases, but not for its components, 
which include elevated blood pressure, myocardial 
infarction or stroke. These authors combined par-
tially edentulous denture wearers and edentulous 
patients without dentures, which made this group 
highly heterogeneous and with potential bias of 
the presence of periodontitis, which complicated 
drawing firm conclusions. This contrasts with peri-
odontitis, where links with blood pressure were 
frequently reported [34]. This may reflect potential 
differences between these two oral conditions.
One potential mechanism explaining the ex-
acerbation of cardiovascular disorders by inflam-
matory oral diseases as DRS is immune system 
activation. However, proving a  cause-and-effect 
relationship between inflammatory diseases of 
the oral cavity, such as DRS, and cardiovascular 
health is particularly difficult due to common risk 
factors including diabetes, hyperlipidaemia, smok-
ing and age [10, 12, 35]. However, the design of 
our study allowed us to minimize the effect of risk 
factors, since the only changing variable was oral 
inflammation. The DRS presence seems to be re-
lated to systemic immune response by influencing 
cytokine production by peripheral immune cells, 
as shown in in vitro studies, where production of 
IL-2 by mononuclear blood cells of DRS patients 
was stimulated in response to Candida albicans 
[36] and high levels of IL-6 and TNF-α were ob-
served in the serum of DRS patients [37]. Howev-
er, systemic activation of the immune response in 
DRS appears to be much more subtle than that ob-
served in chronic periodontitis, in which levels of 
IL-6, CRP, TNF-α and other cytokines are elevated 
[7, 8]. Likewise, a possible role of reactive oxygen 
species and enzymes associated with their pro-
duction, which is important in vascular pathology 
[38], as well as in other diseases [39], cannot be 
excluded.
The present study is limited by the fact that 
we were unable to study a placebo-treated group. 
It was deemed unethical to leave patients with 
clearly evident fungal infection without suffi-
cient anti-fungal treatment for the duration of 
the study. Therefore we had to focus on compar-
isons in relation to pre-treatment status. While 
the number of subjects is not very high and the 
length of follow-up period is not very long, they 
were sufficient to record a clear, statistically sig-
nificant improvement of endothelial function, 
which was the main endpoint of the study. The 
evidence of continued improvement in endothe-
lial function following the completion of nystatin 
therapy is of particular importance, because it in-
dicates that the improvement was related to the 
lack of oral inflammation rather than to a direct 
effect of nystatin. We monitored the most reliable 
indicator of endothelial function – flow-mediat-
ed dilatation [40]. In future it would be valuable 
to address some other biomarkers of endothelial 
health with all the limitations of these, including 
soluble adhesion molecules, ADMA and von Wil-
lebrand factor, as well as others [9, 41–44]. Pre-
dominance of women in the study group could 
also be a limitation to the generalizability of the 
study findings; however, the study population is 
consistent with the epidemiology of DRS. This fact 
should be taken into account before translation 
of the results to the general population. Moreover, 
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the population of elderly women is prone to spe-
cific, menopause-related processes, such as oste-
oporosis [45]. However, given the fact of lack of 
available data on this aspect and the importance 
of detected associations, we believe that these 
findings may become a starting point for further 
studies, which broaden the knowledge and raise 
awareness about the associations between DRS 
and oral health in general and patients’ systemic 
health and well-being.
In conclusion, the most significant observation 
of our research is improvement of endothelial func-
tion in relation to DRS treatment. Since endothelial 
dysfunction is known to precede the development 
of more severe cardiovascular disorders, patients 
should be more carefully screened for DRS in gen-
eral dental practice, and immediate DRS treatment 
should be advised in future dental guidelines.
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